December 12, 2024 18:34 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Amid Atul Subhash row, SC says mere harassment is not enough to prove abetment to suicide | India's D Gukesh becomes youngest ever world champion in chess | Devendra Fadnavis meets PM Modi amid suspense over Maharashtra portfolio allocation | Congress wants to deviate the issue of Sonia Gandhi-George Soros link: JP Nadda | Bengaluru techie suicide: Atul Subhash's family demanded Rs. 10 lakh as dowry leading to my father's death, claims estranged wife | Syria rebels torch tomb of ousted president Bashar al-Assad's father | Donald Trump vows to eliminate birthright citizenship after taking charge | No alliance with Congress in Delhi polls: AAP chief Arvind Kejriwal | Bengaluru techie's suicide: Atul Subhash's wife and her family booked | Bengaluru techie's suicide: Atul Subhash's wife and her family booked

China upset over disclosure of its vaccine price in Bangladesh

Jun 07, 2021, at 01:52 am

Bangladesh Foreign Minister AK Abdul Momen has said China is a little upset that the procurement price of Sinopharm vaccine was made public in Bangladesh, The Daily Star reported.

WHO approves Chinese COVID-19 vaccine for emergency use

May 08, 2021, at 06:58 pm

New York: A COVID-19 vaccine produced in China has been given the green light for global rollout, potentially paving the way for its use in underserved countries, the World Health Organization (WHO) announced on Friday.  

Chinese vaccine candidate based on inactivated SARS-CoV-2 virus appears safe and induces an immune response in healthy volunteers: Study   

Nov 18, 2020, at 02:23 pm

Results from an early-phase randomised clinical trial of a Chinese vaccine candidate based on the inactivated whole SARS-CoV-2 virus (CoronaVac) are published today in The Lancet Infectious Diseases journal, finding the formulation appears safe and induces an antibody response in healthy volunteers aged 18 to 59 years.

Chinese vaccine trials in Brazil to resume after situation analysis by committee : Reports

Nov 11, 2020, at 04:16 pm

Buenos Aires/Sputnik: Trials of the Chinese vaccine Coronavac in Brazil will resume after an analysis of the situation by a special committee, according to the G1 portal, which cited National Health Surveillance Agency ANVISA chief Antonio Torres.